<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01201655</url>
  </required_header>
  <id_info>
    <org_study_id>chenyong</org_study_id>
    <nct_id>NCT01201655</nct_id>
  </id_info>
  <brief_title>Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis</brief_title>
  <official_title>Multicentric Retrospective Case Control Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fourth Military Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Health Science Center of Xiâ€™an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Xijing Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the impact of splenectomy coupled with
      portal-azygous disconnection on hepatocarcinogenesis in patients with post-hepatitic
      cirrhosis after hepatitis B or C virus infection by retrospective case-control study,We hope
      to find a new idear and method to prevent or cure HCC.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A case-control study was carried out. The factors studied include age, gender, ascites,
      hepatic encephalopathy, ALT, AST, TBIL, ALP, GGT, Child-Pugh classification of liver
      function, and history of splenectomy with portal-azygous disconnection during the treatment
      of portal hypertension. According to the Child-Pugh classification, these cases were graded
      as A, B, and C. And according to the ranges of the normal reference values of the data, they
      were categorized into two groups including a normal group and an abnormal group.The data
      mainly comes from FMMU and Xi'an jiaotong university from the year of 2002 to 2012.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Liver Cirrhosis</condition>
  <condition>Carcinoma, Hepatocellular</condition>
  <condition>Splenomegaly</condition>
  <condition>Laparotomy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        post-hepatitic cirrhosis with portal hypertension and hypersplenism patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  after surgery

        Exclusion Criteria:

          -  without surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chen yong, professor</last_name>
    <role>Study Director</role>
    <affiliation>Xia jielai</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chen yong, professor</last_name>
    <phone>13891915509</phone>
    <email>cheny@fmmu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chen yong</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chen yong, professor</last_name>
      <phone>13891915509</phone>
      <email>cheny@fmmu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Li zhe, professor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 13, 2010</study_first_submitted>
  <study_first_submitted_qc>September 13, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2010</study_first_posted>
  <last_update_submitted>September 13, 2010</last_update_submitted>
  <last_update_submitted_qc>September 13, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 14, 2010</last_update_posted>
  <responsible_party>
    <name_title>chen yong</name_title>
    <organization>Xijing Hospital</organization>
  </responsible_party>
  <keyword>Posthepatitic cirrhosis;</keyword>
  <keyword>Hepatocarcinogenesis;</keyword>
  <keyword>Splenectomy;</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Liver Cirrhosis</mesh_term>
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
    <mesh_term>Splenomegaly</mesh_term>
    <mesh_term>Hypersplenism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

